Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective study
- PMID: 33614893
- PMCID: PMC7882528
- DOI: 10.1002/trc2.12122
Association of the use of hearing aids with the conversion from mild cognitive impairment to dementia and progression of dementia: A longitudinal retrospective study
Abstract
Introduction: Hearing aid usage has been linked to improvements in cognition, communication, and socialization, but the extent to which it can affect the incidence and progression of dementia is unknown. Such research is vital given the high prevalence of dementia and hearing impairment in older adults, and the fact that both conditions often coexist. In this study, we examined for the first time the effect of the use of hearing aids on the conversion from mild cognitive impairment (MCI) to dementia and progression of dementia.
Methods: We used a large referral-based cohort of 2114 hearing-impaired patients obtained from the National Alzheimer's Coordinating Center. Survival analyses using multivariable Cox proportional hazards regression model and weighted Cox regression model with censored data were performed to assess the effect of hearing aid use on the risk of conversion from MCI to dementia and risk of death in hearing-impaired participants. Disease progression was assessed with Clinical Dementia Rating Sum of Boxes (CDR-SB) scores. Three types of sensitivity analyses were performed to validate the robustness of the results.
Results: MCI participants that used hearing aids were at significantly lower risk of developing all-cause dementia compared to those not using hearing aids (hazard ratio [HR] 0.73, 95% confidence interval [CI], 0.61 to 0.89; false discovery rate [FDR] P = 0.004). The mean annual rate of change (standard deviation) in CDR-SB scores for hearing aid users with MCI was 1.3 (1.45) points and significantly lower than for individuals not wearing hearing aids with a 1.7 (1.95) point increase in CDR-SB per year (P = 0.02). No association between hearing aid use and risk of death was observed. Our findings were robust subject to sensitivity analyses.
Discussion: Among hearing-impaired adults, hearing aid use was independently associated with reduced dementia risk. The causality between hearing aid use and incident dementia should be further tested.
Keywords: Alzheimer's disease; National Alzheimer's Coordinating Center; cognitive decline; dementia; dementia incidence; dementia onset; disease progression; hearing aid; hearing impairment; hearing loss; mild cognitive impairment; risk factor.
© 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
The impact of hearing impairment and hearing aid use on progression to mild cognitive impairment in cognitively healthy adults: An observational cohort study.Alzheimers Dement (N Y). 2022 Feb 22;8(1):e12248. doi: 10.1002/trc2.12248. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35229022 Free PMC article.
-
Linking higher amyloid beta 1-38 (Aβ(1-38)) levels to reduced Alzheimer's disease progression risk.Alzheimers Dement. 2025 Feb;21(2):e14545. doi: 10.1002/alz.14545. Epub 2025 Jan 27. Alzheimers Dement. 2025. PMID: 39868793 Free PMC article.
-
Visual Evaluation of Medial Temporal Lobe Atrophy as a Clinical Marker of Conversion from Mild Cognitive Impairment to Dementia and for Predicting Progression in Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease.Dement Geriatr Cogn Disord. 2017;44(1-2):12-24. doi: 10.1159/000477342. Epub 2017 Jun 15. Dement Geriatr Cogn Disord. 2017. PMID: 28614836
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. PMID: 32129963 Free Books & Documents. Review.
Cited by
-
ENHANCE: a comparative prospective longitudinal study of cognitive outcomes after 3 years of hearing aid use in older adults.Front Aging Neurosci. 2024 Jan 31;15:1302185. doi: 10.3389/fnagi.2023.1302185. eCollection 2023. Front Aging Neurosci. 2024. PMID: 38356856 Free PMC article.
-
Early detection and management of hearing loss to reduce dementia risk in older adults with mild cognitive impairment: findings from the treating auditory impairment and cognition trial (TACT).Age Ageing. 2025 Jan 6;54(1):afaf004. doi: 10.1093/ageing/afaf004. Age Ageing. 2025. PMID: 39835654 Free PMC article. Clinical Trial.
-
The trend in adoption of hearing aids following changes in provision policy in South Korea.Sci Rep. 2022 Aug 4;12(1):13389. doi: 10.1038/s41598-022-17459-7. Sci Rep. 2022. PMID: 35927560 Free PMC article.
-
Umbrella review and Delphi study on modifiable factors for dementia risk reduction.Alzheimers Dement. 2024 Mar;20(3):2223-2239. doi: 10.1002/alz.13577. Epub 2023 Dec 30. Alzheimers Dement. 2024. PMID: 38159267 Free PMC article.
-
Hearing Loss and Dementia Prevalence in Older Adults in the US.JAMA. 2023 Jan 10;329(2):171-173. doi: 10.1001/jama.2022.20954. JAMA. 2023. PMID: 36625819 Free PMC article.
References
-
- Alzheimer's Association . Changing the Trajectory of Alzheimer's Disease: A National Imperative. USA: Alzheimer's Association; 2010.
-
- Yaffe K. Modifiable risk factors and prevention of dementia: what is the latest evidence? JAMA Intern Med. 2018;178(2):281‐282. - PubMed
Grants and funding
- P50 AG005142/AG/NIA NIH HHS/United States
- P50 AG005146/AG/NIA NIH HHS/United States
- P50 AG047266/AG/NIA NIH HHS/United States
- P30 AG008017/AG/NIA NIH HHS/United States
- P30 AG010161/AG/NIA NIH HHS/United States
- P50 AG025688/AG/NIA NIH HHS/United States
- P50 AG005133/AG/NIA NIH HHS/United States
- P50 AG005138/AG/NIA NIH HHS/United States
- P50 AG047366/AG/NIA NIH HHS/United States
- P30 AG019610/AG/NIA NIH HHS/United States
- MR/L023784/2/MRC_/Medical Research Council/United Kingdom
- P30 AG028383/AG/NIA NIH HHS/United States
- P30 AG013854/AG/NIA NIH HHS/United States
- P30 AG053760/AG/NIA NIH HHS/United States
- P30 AG066444/AG/NIA NIH HHS/United States
- P30 AG062428/AG/NIA NIH HHS/United States
- P30 AG010124/AG/NIA NIH HHS/United States
- P50 AG023501/AG/NIA NIH HHS/United States
- MR/T033371/1/MRC_/Medical Research Council/United Kingdom
- P30 AG010133/AG/NIA NIH HHS/United States
- P30 AG062421/AG/NIA NIH HHS/United States
- P30 AG035982/AG/NIA NIH HHS/United States
- P50 AG008702/AG/NIA NIH HHS/United States
- U01 AG016976/AG/NIA NIH HHS/United States
- P30 AG008051/AG/NIA NIH HHS/United States
- P50 AG005681/AG/NIA NIH HHS/United States
- P30 AG013846/AG/NIA NIH HHS/United States
- P50 AG047270/AG/NIA NIH HHS/United States
- P30 AG062429/AG/NIA NIH HHS/United States
- P50 AG005136/AG/NIA NIH HHS/United States
- P30 AG049638/AG/NIA NIH HHS/United States
- P30 AG012300/AG/NIA NIH HHS/United States
- P30 AG062422/AG/NIA NIH HHS/United States
- P50 AG016573/AG/NIA NIH HHS/United States
- P30 AG062715/AG/NIA NIH HHS/United States
- P30 AG010129/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources